HRP20041152B1 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
HRP20041152B1
HRP20041152B1 HR20041152A HRP20041152A HRP20041152B1 HR P20041152 B1 HRP20041152 B1 HR P20041152B1 HR 20041152 A HR20041152 A HR 20041152A HR P20041152 A HRP20041152 A HR P20041152A HR P20041152 B1 HRP20041152 B1 HR P20041152B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical formulations
disintegrating
seconds
characterized
dosage form
Prior art date
Application number
HR20041152A
Other languages
Croatian (hr)
Unknown language (xx)
Inventor
Anders Lars
Lindner Hans
Jørgen Wittendorff Jansen
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0210397.6A priority Critical patent/GB0210397D0/en
Priority to PCT/IB2002/004036 priority patent/WO2003094885A1/en
Priority to PCT/IB2003/002368 priority patent/WO2003094886A2/en
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of HRP20041152A2 publication Critical patent/HRP20041152A2/en
Publication of HRP20041152B1 publication Critical patent/HRP20041152B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

Orodisperzibilni farmaceutski oblik doziranja desmopresin acetata, naznačen time, da se razgrađuje u ustima u roku od 10 sekundi. Orodispersible pharmaceutical dosage form of desmopressin acetate, characterized in that the disintegrating within 10 seconds. Patent sadrži još 16 patentnih zahtjeva. The patent contains 16 claims.
HR20041152A 2002-05-07 2004-12-03 Pharmaceutical formulations HRP20041152B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0210397.6A GB0210397D0 (en) 2002-05-07 2002-05-07 Pharmaceutical formulations
PCT/IB2002/004036 WO2003094885A1 (en) 2002-05-07 2002-09-20 Sublingual pharmaceutical formulation of desmopressin
PCT/IB2003/002368 WO2003094886A2 (en) 2002-05-07 2003-05-07 Desmopressin in an orodispersible dosage form

Publications (2)

Publication Number Publication Date
HRP20041152A2 HRP20041152A2 (en) 2005-04-30
HRP20041152B1 true HRP20041152B1 (en) 2008-01-31

Family

ID=29422105

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20041152A HRP20041152B1 (en) 2002-05-07 2004-12-03 Pharmaceutical formulations

Country Status (10)

Country Link
JP (1) JP2006502972A (en)
AU (1) AU2003233118B8 (en)
BR (1) BR0309819A (en)
CA (1) CA2484724C (en)
DE (2) DE60307082T4 (en)
HR (1) HRP20041152B1 (en)
NO (1) NO335167B1 (en)
NZ (1) NZ535861A (en)
PT (1) PT1501534E (en)
WO (1) WO2003094886A2 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
JP4523265B2 (en) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 Dysuria treatment for orally disintegrating formulation
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE60301351T2 (en) 2003-07-25 2006-01-19 Ferring B.V. Pharmaceutical desmopressin preparation as a solid dosage form and method for their preparation
CN1878563A (en) * 2003-11-10 2006-12-13 西摩·H·费恩 Pharmaceutical compositions including low dosages of desmopressin
DE60305043T2 (en) * 2003-11-13 2006-11-30 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
DK1550439T3 (en) * 2003-12-29 2006-04-03 Ferring Bv A process for the preparation of solid dosage forms of desmopressin
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
GB0406048D0 (en) * 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
SE0600482L (en) * 2006-03-02 2006-11-14 Ferring Int Ct Sa A pharmaceutical composition comprising desmopressin, silica and starch
WO2007098945A2 (en) * 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
US8273770B2 (en) 2007-07-21 2012-09-25 Albany Molecular Research, Inc. 5-pyridinone substituted indazoles
JP5451613B2 (en) * 2007-08-06 2014-03-26 アラーガン、インコーポレイテッドAllergan,Incorporated Method and device for desmopressin drug delivery
CN103351390A (en) 2007-11-21 2013-10-16 解码遗传Ehf公司 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
EP2240481A1 (en) 2008-01-11 2010-10-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT3225249T (en) * 2008-05-21 2019-01-10 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
AU2010207486B2 (en) 2009-01-26 2013-03-07 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
TWI468157B (en) * 2009-04-29 2015-01-11 Intervet Int Bv Process to form a tablet, system for performing this process and package comprising the tablet
TWI471127B (en) * 2009-04-29 2015-02-01 Intervet Int Bv A process for preparing an orally disintegrating tablet for human use, an orally disintegrating tablet thus obtained and a package containing the orally disintegrating tablet
KR101792696B1 (en) 2009-06-18 2017-11-02 알레간 인코포레이티드 Safe desmopressin administration
AU2010273732A1 (en) 2009-07-14 2012-02-09 Albany Molecular Research, Inc. 5-HT3 receptor modulators, methods of making, and use thereof
JO3112B1 (en) * 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
NZ706991A (en) 2010-03-29 2016-08-26 Ferring Bv A fast dissolving pharmaceutical composition
DK2624815T3 (en) * 2010-10-08 2016-11-07 Scherer Technologies Llc R P Oral vaccine in rapidly dissolving dosage form using starch
JP2011116764A (en) * 2011-02-08 2011-06-16 Fine Seymour H Medical composition containing low dose desmopressin
US9731018B2 (en) 2011-09-16 2017-08-15 Ferring B.V. Fast dissolving pharmaceutical composition
JP5928159B2 (en) * 2012-05-28 2016-06-01 ニプロ株式会社 Pharmaceutical compositions
TW201422254A (en) * 2012-11-21 2014-06-16 Ferring Bv Composition for immediate and extended release
CN103993061B (en) * 2014-05-20 2018-03-23 海南美合泰生物科技有限公司 Method for producing fish collagen
KR20150144209A (en) * 2014-06-16 2015-12-24 훼링 비.브이. Pharmaceutical composition comprising stabilized desmopressin or pharmaceutically acceptable salt thereof
JP6341777B2 (en) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス,エルエルシー Pharmaceutical compositions containing a low dose desmopressin

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
EP0517211A1 (en) * 1991-06-07 1992-12-09 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide containing pharmaceutical composition
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
WO2000044251A1 (en) * 1999-01-27 2000-08-03 Spenco Medical Corporation Therapeutic magnetic insoles
WO2000059423A1 (en) * 1999-04-01 2000-10-12 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
WO2000061117A1 (en) * 1999-04-08 2000-10-19 R.P. Scherer Corporation Fast-dispersing dosage forms containing fish gelatin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3253127B2 (en) * 1991-06-07 2002-02-04 帝國製薬株式会社 Physiologically active polypeptide-containing preparation
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
EP0517211A1 (en) * 1991-06-07 1992-12-09 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide containing pharmaceutical composition
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
WO2000044251A1 (en) * 1999-01-27 2000-08-03 Spenco Medical Corporation Therapeutic magnetic insoles
WO2000059423A1 (en) * 1999-04-01 2000-10-12 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
WO2000061117A1 (en) * 1999-04-08 2000-10-19 R.P. Scherer Corporation Fast-dispersing dosage forms containing fish gelatin

Also Published As

Publication number Publication date
CA2484724C (en) 2007-01-16
JP2006502972A (en) 2006-01-26
BR0309819A (en) 2005-03-01
AU2003233118B8 (en) 2009-07-30
NZ535861A (en) 2006-11-30
AU2003233118A1 (en) 2003-11-11
WO2003094886A2 (en) 2003-11-20
HRP20041152A2 (en) 2005-04-30
NO335167B1 (en) 2014-10-06
DE60307082T4 (en) 2015-04-30
NO20045345L (en) 2005-02-07
WO2003094886A3 (en) 2004-07-22
CA2484724A1 (en) 2003-11-20
PT1501534E (en) 2006-09-29
AU2003233118B2 (en) 2006-10-26
DE60307082D1 (en) 2006-09-07
DE60307082T2 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
DK1263720T3 (en) Azetidine derivatives, the preparation thereof and to pharmaceutical compositions containing the same
RU2005101639A (en) The sustained-release tablet, comprising reboxetine
NO328865B1 (en) Pharmaceutical compositions and immunogenic agent and the use thereof
SA99200090A (en) Bicyclic hydroxamic acid derivatives.
NO329492B1 (en) The use of immunostimulatory oligodeoksynukleinsyremolekyler for preparation of immunostimulatory, pharmaceutical compositions and pharmaceutical compositions containing the same.
NO324249B1 (en) Glykopyranosyloksybenzylbenzenderivater, medical compositions containing them, and intermediates for the preparation of derivatives
EE200300145A (en) And the pharmaceutical composition and the aza polüasanaftalenüülkarboksamiidid
UA83458C2 (en) The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf)
DK2455083T3 (en) A pharmaceutical composition for dermal use comprising calcipotriol and betamethasone, for the treatment of psoriasis
NO329386B1 (en) Glucocorticoids-mimetic, pharmaceutical compositions and uses for the preparation of medikamenterfor treating disease
NO992941D0 (en) The drug delivery and -emballering
RU2003136754A (en) Improvements in the delivery of programs
MA26800A1 (en) Systems and methods aerosols for pharmaceutical formulations.
ES2126536B1 (en) "Pharmaceutical preparation for intranasal administration and procedimientopara their production."
NO20041277L (en) Pharmaceutical compositions for the treatment of asthma.
DE60117615D1 (en) Drug combinations (eg, chlorpromazine and pentamidine) for the treatment of neoplastic diseases
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
EE05257B1 (en) K? Practices of the pellets in the form of pharmaceutical preparations kuivpulberinhalaatoritele
NO20024181L (en) Lipidnanokapsler, process for their preparation and the use of the drug
NO323724B1 (en) Substituted piperazine and piperidine compounds, the use of such compounds for the manufacture of a medicament for the treatment of pain, stroke or epilepsy as well as pharmaceutical compositions comprising such compounds.
RU2000123156A (en) Rapidly cleaved pharmaceutical dosage form
RU2003116898A (en) Combinations of drugs (e.g. chlorpromazine and pentamidine) for the treatment of neoplastic disorders
NO328731B1 (en) Quinazoline compounds and the use and process feed for the preparation thereof, and pharmaceutical compositions.
NO20001409L (en) Karboksamidotiazolderivater, fremgangsmÕte for the preparation thereof and pharmaceutical compositions
EA200501586A1 (en) pharmaceutical products